Form 4 for REGN Regeneron Pharmaceuticals
Accepted 2021-12-10 00:00:00 ET · period of report 2021-12-08 · accession 0001708138-21-000098 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-12-10 | 2021-12-10 | REGN | MURPHY ANDREW J | EVP Research | S - Sale+OE | $666.27 | -7,122 | 64.1K | -10% | -$4.75M |
| D | 2021-12-10 | 2021-12-09 | REGN | MURPHY ANDREW J | EVP Research | F - Tax | $657.11 | -9,378 | 66.3K | -12% | -$6.16M |
| D | 2021-12-10 | 2021-12-09 | REGN | MURPHY ANDREW J | EVP Research | M - OptEx | $52.03 | +16.5K | 75.7K | +28% | +$858.5K |
| D | 2021-12-10 | 2021-12-08 | REGN | MURPHY ANDREW J | EVP Research | A - Grant | $0.00 | +3,462 | 59.2K | +6% | $0 |
| D | 2021-12-10 | 2021-12-08 | REGN | MURPHY ANDREW J | EVP Research | A - Grant | $0.00 | +14.8K | 14.8K | New | $0 |
| D | 2021-12-10 | 2021-12-09 | REGN | MURPHY ANDREW J | EVP Research | M - OptEx | $0.00 | -16.5K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-10 | S | D | 1,018 | $669.60 | 60,296 | D | — | — | (F15) Represents volume-weighted average price of sales of 1,018 shares of Company stock on December 10, 2021 at prices ranging from $669.03 to $669.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price. |
| 2 | Common | Common Stock | 2021-12-10 | S | D | 872 | $670.68 | 59,424 | D | — | — | (F16) Represents volume-weighted average price of sales of 872 shares of Company stock on December 10, 2021 at prices ranging from $670.11 to $670.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price. |
| 3 | Common | Common Stock | 2021-12-10 | S | D | 219 | $671.33 | 59,205 | D | — | — | (F17) Represents volume-weighted average price of sales of 219 shares of Company stock on December 10, 2021 at prices ranging from $671.19 to $671.39. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price. |
| 4 | Common | Common Stock | 2021-12-10 | S | D | 38 | $672.30 | 59,167 | D | — | — | |
| 5 | Common | Common Stock | 2021-12-10 | S | D | 1,738 | $668.42 | 61,314 | D | — | — | (F14) Represents volume-weighted average price of sales of 1,738 shares of Company stock on December 10, 2021 at prices ranging from $668.10 to $668.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price. |
| 6 | Common | Common Stock | 2021-12-10 | S | D | 280 | $667.50 | 63,052 | D | — | — | (F13) Represents volume-weighted average price of sales of 280 shares of Company stock on December 10, 2021 at prices ranging from $667.01 to $667.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price. |
| 7 | Common | Common Stock | 2021-12-10 | S | D | 384 | $666.40 | 63,332 | D | — | — | (F12) Represents volume-weighted average price of sales of 384 shares of Company stock on December 10, 2021 at prices ranging from $666.06 to $666.73. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price. |
| 8 | Common | Common Stock | 2021-12-10 | S | D | 404 | $665.29 | 63,716 | D | — | — | (F11) Represents volume-weighted average price of sales of 404 shares of Company stock on December 10, 2021 at prices ranging from $665.03 to $665.82. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price. |
| 9 | Common | Common Stock | 2021-12-10 | S | D | 272 | $663.61 | 64,278 | D | — | — | (F9) Represents volume-weighted average price of sales of 272 shares of Company stock on December 10, 2021 at prices ranging from $663.14 to $663.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price. |
| 10 | Common | Common Stock | 2021-12-10 | S | D | 354 | $662.36 | 64,550 | D | — | — | (F8) Represents volume-weighted average price of sales of 354 shares of Company stock on December 10, 2021 at prices ranging from $662.06 to $662.68. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price. |
| 11 | Common | Common Stock | 2021-12-10 | S | D | 282 | $661.57 | 64,904 | D | — | — | (F7) Represents volume-weighted average price of sales of 282 shares of Company stock on December 10, 2021 at prices ranging from $661.27 to $661.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price. |
| 12 | Common | Common Stock | 2021-12-10 | S | D | 4 | $660.45 | 65,186 | D | — | — | (F6) Represents volume-weighted average price of sales of 4 shares of Company stock on December 10, 2021 at prices ranging from $660.38 to $660.47. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price. |
| 13 | Common | Common Stock | 2021-12-10 | S | D | 370 | $659.29 | 65,190 | D | — | — | (F5) Represents volume-weighted average price of sales of 370 shares of Company stock on December 10, 2021 at prices ranging from $659.29 to $659.68. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price. |
| 14 | Common | Common Stock | 2021-12-10 | S | D | 330 | $658.78 | 65,560 | D | — | — | (F4) Represents volume-weighted average price of sales of 330 shares of Company stock on December 10, 2021 at prices ranging from $658.02 to $658.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price. |
| 15 | Common | Common Stock | 2021-12-10 | S | D | 399 | $657.61 | 65,890 | D | — | — | (F3) Represents volume-weighted average price of sales of 399 shares of Company stock on December 10, 2021 at prices ranging from $657.27 to $657.92. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price. |
| 16 | Common | Common Stock | 2021-12-09 | F | D | 9,378 | $657.11 | 66,289 | D | — | — | |
| 17 | Common | Common Stock | 2021-12-09 | M | A | 16,500 | $52.03 | 75,667 | D | — | — | |
| 18 | Common | Common Stock | 2021-12-08 | A | A | 3,462 | $0.00 | 59,167 | D | — | — | |
| 19 | Common | Common Stock | 2021-12-10 | S | D | 158 | $664.28 | 64,120 | D | — | — | (F10) Represents volume-weighted average price of sales of 158 shares of Company stock on December 10, 2021 at prices ranging from $664.06 to $664.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price. |
| 20 | Derivative | Non-Qualified Stock Option (right to buy) | 2021-12-08 | A | A | 14,783 | $0.00 | 14,783 | D | $644.54 · — to 2031-12-08 | 14,783 Common Stock | (F18) The stock option award vests in four equal annual installments, commencing one year after the date of grant. |
| 21 | Derivative | Non-Qualified Stock Option (right to buy) | 2021-12-09 | M | D | 16,500 | $0.00 | 0 | D | $52.03 · — to 2021-12-16 | 16,500 Common Stock | (F18) The stock option award vests in four equal annual installments, commencing one year after the date of grant. |